newsfilter
← Latest News
Business Wire·

CEL-SCI Announces Pricing of $10 Million Public Offering

CEL-SCI Corporation ("CEL-SCI" or the "Company") (NYSE:CVM), a clinical stage cancer immunotherapy company, today announced the pricing of a best-efforts public offering of 1,111,200 shares of its common stock. Each